GlassScriptPhysician profile
Michelle Stiles
NPI 1386256790
$3,898.07
in general payments reported to CMS, 2019-2025
21 companies · $738 in 2025
The $738 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.88 · 2023: $1,610 · 2024: $1,522 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405 · Education: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,405.23 |
| Education | $464.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $639.99 | 2022-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $553.81 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $475.93 | 2023-2025 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $388.31 | 2023-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $295.65 | 2023 | Myrisk, Precisetumor, Prolaris |
| Verity Pharmaceuticals INC. | $271.88 | 2024-2025 | Trelstar |
| Ferring Pharmaceuticals INC. | $187.79 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $153.82 | 2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $150.00 | 2023 | |
| Accord Healthcare, INC. | $137.04 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $105.41 | 2023 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $98.91 | 2023-2024 | Pylarify |
| Sun Pharmaceutical Industries INC. | $93.01 | 2023-2024 | Yonsa |
| Pfizer INC. | $66.72 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $65.64 | 2023-2025 | Keytruda, Lynparza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $59.01 | 2023-2024 | |
| Endo USA, INC. | $56.58 | 2024-2025 | Aveed, Xiaflex |
| Boston Scientific Corporation | $49.13 | 2025 | Lithovue |
| Alnylam Pharmaceuticals INC. | $17.97 | 2023 | Oxlumo |
| Abbvie INC. | $17.26 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Stiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.